Evotec Shares Surge 13.3% as Triton Considers Takeover with Near 10% Stake

Nov 11, 2024, 11:00 AM

Shares in Evotec jumped as much as 13.3% on Monday after regulatory filings showed that private equity firm Triton had built an over 9% stake in the German drug development company. Triton Partners is considering a takeover bid for Evotec, following its emergence as one of the drug developer’s largest shareholders. Triton has become the biggest shareholder with a near 10% stake.